Milestone Scientific (MLSS) 2.9700 $MLSS
Milestone Scientific Provides Business Update Regarding Launch of New Medical Instruments
Marketwired - Mon Feb 09, 8:43AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today provided a business update on the status of its new medical instruments based on Milestone's computer-controlled injection and drug delivery technology. These new medical instruments represent an alternative to the syringe and are designed to provide cost reductions, safe, controlled painless injections.
Milestone Scientific to Present at The Brewer Group Innovations Conference
Marketwired - Fri Feb 06, 7:11AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present on Monday, February 9th at 11:00 a.m. EST at The Brewer Group Innovations Conference. The conference is being held at the Mondrian South Beach in Miami, Florida.
Milestone Scientific Announces Distribution Agreement for Intra-Articular Instrument in China
Marketwired - Mon Dec 22, 7:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that through its minority owned subsidiary, Milestone Medical, exclusive licensee of Milestone Scientific's epidural and intra-articular instruments, it has entered into a distribution agreement with Milestone China for its intra-articular instrument to be used in the treatment of osteoarthritis. Milestone China will oversee sales and distribution of the instrument in China and other parts of Asia. Under the agreement, Milestone China has agreed to certain minimum purchases annually following CFDA marketing clearance as a condition of the distribution agreement. Year one minimum purchase is 300 instruments; year two is 600 instruments and year three is 800 instruments. CFDA marketing clearance can be sought only following FDA marketing clearance in the United States. Although companies have no control over the regulatory process, Milestone currently believes it will have approval by the end of the second quarter of 2015.
Milestone Scientific Appoints Steven F. Robins as President of Milestone Scientific and Milestone Medical
Marketwired - Tue Dec 16, 7:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced the appointment of Steven F. Robins as President of Milestone Scientific and Milestone Medical, exclusive licensee of Milestone Scientific's epidural and intra-articular instruments.
JNJ: 99.62 (+1.18)
Milestone Scientific Announces Distribution Agreement for Epidural Instrument in China
Marketwired - Thu Dec 11, 7:58AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that through its minority owned subsidiary, Milestone Medical, exclusive licensee of Milestone Scientific's epidural and intra-articular instruments, it has entered into a distribution agreement with Milestone China for its epidural instrument. Milestone China will oversee sales and distribution of the instrument in China and other parts of Asia. Under the agreement, Milestone China has agreed to certain minimum purchases following CFDA marketing clearance as a condition of the distribution agreement. Year one minimum purchase is 250 instruments; year two is 550 instruments and year three is 750 instruments. CFDA marketing clearance can be sought only following FDA marketing clearance in the United States, which is not expected before mid-2015.
Milestone Scientific to Present at the LD Micro Conference on December 4th
Marketwired - Wed Nov 26, 8:21AM CST
Milestone Scientific Inc. (OTCQB: MLSS ), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that Leslie Bernhard, Chairman of the Board, will make a presentation on Thursday, December 4th, 2014 at 3:00 PM PST / 6:00 PM EST, Track 3 at the LD Micro Main Event VII Conference. The conference is being held December 2-4, 2014 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.
Milestone Scientific Announces Financial Results for the Third Quarter of 2014
Marketwired - Tue Nov 18, 11:19PM CST
Milestone Scientific Inc.(OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced financial results and provided a business update for the three and nine months ended September 30, 2014.
Milestone Scientific's (MLSS) Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 17, 5:53PM CST
Milestone Sci reports November 17
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 9:13AM CST
Milestone Scientific Schedules Third Quarter 2014 Earnings Conference Call
Marketwired - Thu Nov 13, 7:51AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will host a conference call at 4:30 p.m. Eastern Time on Monday, November 17, 2014 to discuss the Company's financial results for the third quarter ended September 30, 2014, as well as the Company's corporate progress and other developments.
Milestone Scientific to Present at the SeeThruEquity Microcap Investor Conference in NYC
Marketwired - Fri Nov 07, 9:45AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present at the SeeThruEquity Microcap Investor Conference on Wednesday, November 12th at 3:00 P.M. EST at the Convene Midtown East in New York City located at 730 Third Avenue.
Milestone Scientific to Present at the FireRock Conference in NYC
Marketwired - Fri Oct 24, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present on Tuesday, October 28th at 9:45 a.m. EST at the FireRock Conference at the Springmills Landmark Building located at 104 West 40th Street, New York, NY.
Milestone Scientific Announces Planned Merger of Its JV, Milestone Ophthalmic Sp. z o.o., With EWH and Listing of Common Stock on the Warsaw Stock Exchange
Marketwire - Mon Sep 22, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its recently formed Joint Venture, Milestone Ophthalmic Sp. z o.o., plans to merge with Emmerson Wierzytelnosci Hipoteczne S.A. ("EWH"
to effect a listing of its common stock on the New Connect market of the Warsaw Stock Exchange, subject to certain final terms and conditions of the merger agreement.
Milestone Scientific Receives CE Mark Approval for Epidural Injection System
Marketwire - Thu Sep 18, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its subsidiary, Milestone Medical, has received CE Mark to market and sell its epidural injection system in Europe. The CompuFlo(TM) Epidural Computer Controlled Anesthesia System (CompuFlo(TM) Epidural Model 6000) is intended for the verification of needle tip placement in the lumbar epidural space in patients over age of 18 and the delivery of medication and other fluids in a controlled manner in the lumbar epidural space as part of an in-patient or out-patient procedure established by their Health Care Provider.
Milestone Scientific and Milestone China Form New Dermatological Joint Venture
Marketwire - Tue Sep 16, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced it has formed a dermatological joint venture with Milestone China. The new joint venture entity, Milestone Advanced Cosmetic Systems, Inc., will be 50% owned by Milestone Scientific and 50% owned by Milestone China. Milestone China will contribute $900,000 and Milestone Scientific will contribute a limited license to use its technology to the joint venture for the development of a botox injection system, consisting of a computer controlled injection device and a related disposable. As previously announced, Milestone China is a joint venture distribution company between Milestone Scientific and a team headed by a senior healthcare executive from China. The focus of Milestone China is to supply and distribute medical and dental instruments, and disposables to China and other Asian markets.
Milestone Scientific passes CE Mark approval for intra-articular instrument
M2 - Mon Sep 15, 7:01AM CDT
Medical company Milestone Scientific (Other OTC:MLSS) disclosed on Monday that its subsidiary, Milestone Medical, has secured CE Mark regulatory approval to market and sell its intra-articular instrument in Europe.
Milestone Scientific Receives CE Mark Approval for Intra-Articular Instrument
Marketwire - Mon Sep 15, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its subsidiary, Milestone Medical, has received CE Mark regulatory approval to market and sell its intra-articular instrument in Europe.
Milestone Scientific Provides Business Update Regarding Launch of New Medical Instruments
Marketwired - Mon Feb 09, 8:43AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today provided a business update on the status of its new medical instruments based on Milestone's computer-controlled injection and drug delivery technology. These new medical instruments represent an alternative to the syringe and are designed to provide cost reductions, safe, controlled painless injections.
Milestone Scientific to Present at The Brewer Group Innovations Conference
Marketwired - Fri Feb 06, 7:11AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present on Monday, February 9th at 11:00 a.m. EST at The Brewer Group Innovations Conference. The conference is being held at the Mondrian South Beach in Miami, Florida.
Milestone Scientific Announces Distribution Agreement for Intra-Articular Instrument in China
Marketwired - Mon Dec 22, 7:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that through its minority owned subsidiary, Milestone Medical, exclusive licensee of Milestone Scientific's epidural and intra-articular instruments, it has entered into a distribution agreement with Milestone China for its intra-articular instrument to be used in the treatment of osteoarthritis. Milestone China will oversee sales and distribution of the instrument in China and other parts of Asia. Under the agreement, Milestone China has agreed to certain minimum purchases annually following CFDA marketing clearance as a condition of the distribution agreement. Year one minimum purchase is 300 instruments; year two is 600 instruments and year three is 800 instruments. CFDA marketing clearance can be sought only following FDA marketing clearance in the United States. Although companies have no control over the regulatory process, Milestone currently believes it will have approval by the end of the second quarter of 2015.
Milestone Scientific Appoints Steven F. Robins as President of Milestone Scientific and Milestone Medical
Marketwired - Tue Dec 16, 7:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced the appointment of Steven F. Robins as President of Milestone Scientific and Milestone Medical, exclusive licensee of Milestone Scientific's epidural and intra-articular instruments.
JNJ: 99.62 (+1.18)
Milestone Scientific Announces Distribution Agreement for Epidural Instrument in China
Marketwired - Thu Dec 11, 7:58AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that through its minority owned subsidiary, Milestone Medical, exclusive licensee of Milestone Scientific's epidural and intra-articular instruments, it has entered into a distribution agreement with Milestone China for its epidural instrument. Milestone China will oversee sales and distribution of the instrument in China and other parts of Asia. Under the agreement, Milestone China has agreed to certain minimum purchases following CFDA marketing clearance as a condition of the distribution agreement. Year one minimum purchase is 250 instruments; year two is 550 instruments and year three is 750 instruments. CFDA marketing clearance can be sought only following FDA marketing clearance in the United States, which is not expected before mid-2015.
Milestone Scientific to Present at the LD Micro Conference on December 4th
Marketwired - Wed Nov 26, 8:21AM CST
Milestone Scientific Inc. (OTCQB: MLSS ), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that Leslie Bernhard, Chairman of the Board, will make a presentation on Thursday, December 4th, 2014 at 3:00 PM PST / 6:00 PM EST, Track 3 at the LD Micro Main Event VII Conference. The conference is being held December 2-4, 2014 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.
Milestone Scientific Announces Financial Results for the Third Quarter of 2014
Marketwired - Tue Nov 18, 11:19PM CST
Milestone Scientific Inc.(OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced financial results and provided a business update for the three and nine months ended September 30, 2014.
Milestone Scientific's (MLSS) Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 17, 5:53PM CST
Milestone Sci reports November 17
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 9:13AM CST
Milestone Scientific Schedules Third Quarter 2014 Earnings Conference Call
Marketwired - Thu Nov 13, 7:51AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will host a conference call at 4:30 p.m. Eastern Time on Monday, November 17, 2014 to discuss the Company's financial results for the third quarter ended September 30, 2014, as well as the Company's corporate progress and other developments.
Milestone Scientific to Present at the SeeThruEquity Microcap Investor Conference in NYC
Marketwired - Fri Nov 07, 9:45AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present at the SeeThruEquity Microcap Investor Conference on Wednesday, November 12th at 3:00 P.M. EST at the Convene Midtown East in New York City located at 730 Third Avenue.
Milestone Scientific to Present at the FireRock Conference in NYC
Marketwired - Fri Oct 24, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present on Tuesday, October 28th at 9:45 a.m. EST at the FireRock Conference at the Springmills Landmark Building located at 104 West 40th Street, New York, NY.
Milestone Scientific Announces Planned Merger of Its JV, Milestone Ophthalmic Sp. z o.o., With EWH and Listing of Common Stock on the Warsaw Stock Exchange
Marketwire - Mon Sep 22, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its recently formed Joint Venture, Milestone Ophthalmic Sp. z o.o., plans to merge with Emmerson Wierzytelnosci Hipoteczne S.A. ("EWH"
to effect a listing of its common stock on the New Connect market of the Warsaw Stock Exchange, subject to certain final terms and conditions of the merger agreement. Milestone Scientific Receives CE Mark Approval for Epidural Injection System
Marketwire - Thu Sep 18, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its subsidiary, Milestone Medical, has received CE Mark to market and sell its epidural injection system in Europe. The CompuFlo(TM) Epidural Computer Controlled Anesthesia System (CompuFlo(TM) Epidural Model 6000) is intended for the verification of needle tip placement in the lumbar epidural space in patients over age of 18 and the delivery of medication and other fluids in a controlled manner in the lumbar epidural space as part of an in-patient or out-patient procedure established by their Health Care Provider.
Milestone Scientific and Milestone China Form New Dermatological Joint Venture
Marketwire - Tue Sep 16, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced it has formed a dermatological joint venture with Milestone China. The new joint venture entity, Milestone Advanced Cosmetic Systems, Inc., will be 50% owned by Milestone Scientific and 50% owned by Milestone China. Milestone China will contribute $900,000 and Milestone Scientific will contribute a limited license to use its technology to the joint venture for the development of a botox injection system, consisting of a computer controlled injection device and a related disposable. As previously announced, Milestone China is a joint venture distribution company between Milestone Scientific and a team headed by a senior healthcare executive from China. The focus of Milestone China is to supply and distribute medical and dental instruments, and disposables to China and other Asian markets.
Milestone Scientific passes CE Mark approval for intra-articular instrument
M2 - Mon Sep 15, 7:01AM CDT
Medical company Milestone Scientific (Other OTC:MLSS) disclosed on Monday that its subsidiary, Milestone Medical, has secured CE Mark regulatory approval to market and sell its intra-articular instrument in Europe.
Milestone Scientific Receives CE Mark Approval for Intra-Articular Instrument
Marketwire - Mon Sep 15, 6:31AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its subsidiary, Milestone Medical, has received CE Mark regulatory approval to market and sell its intra-articular instrument in Europe.
